{"result": "(\"entity\"<|>ROSA Mª MIRETE LÓPEZ<|>PERSON<|>Rosa Mª Mirete López is a specialist in Endocrinology and Nutrition at Hospital Universitario de San Juan, Alicante, who treated a patient with diabetes mellitus and inflammatory bowel disease.)\n##\n(\"entity\"<|>HOSPITAL UNIVERSITARIO DE SAN JUAN<|>ORGANIZATION<|>Hospital Universitario de San Juan is a medical facility located in Alicante where Rosa Mª Mirete López works.)\n##\n(\"entity\"<|>DIABETES MELLITUS<|>EVENT<|>Diabetes mellitus is a chronic condition that affects the body's ability to process blood glucose, which was diagnosed in the patient during hospitalization.)\n##\n(\"entity\"<|>INFLAMMATORY BOWEL DISEASE<|>EVENT<|>Inflammatory bowel disease is a term for disorders involving chronic inflammation of the digestive tract, which the patient was suffering from.)\n##\n(\"entity\"<|>ILEOSTOMY<|>EVENT<|>Ileostomy is a surgical procedure that creates an opening in the abdominal wall for waste to exit the body, performed on the patient due to complications.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Nutritional support provided intravenously to the patient, which was necessary during her hospitalization.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Enteral nutrition is a method of feeding that uses the gastrointestinal tract, initiated for the patient through a nasogastric tube.)\n##\n(\"relationship\"<|>ROSA Mª MIRETE LÓPEZ<|>HOSPITAL UNIVERSITARIO DE SAN JUAN<|>Rosa Mª Mirete López is a specialist working at Hospital Universitario de San Juan where she treated the patient<|>8)\n##\n(\"relationship\"<|>DIABETES MELLITUS<|>INFLAMMATORY BOWEL DISEASE<|>The patient was diagnosed with diabetes mellitus while also suffering from inflammatory bowel disease<|>6)\n##\n(\"relationship\"<|>ROSA Mª MIRETE LÓPEZ<|>DIABETES MELLITUS<|>Rosa Mª Mirete López treated the patient who was diagnosed with diabetes mellitus<|>7)\n##\n(\"relationship\"<|>ROSA Mª MIRETE LÓPEZ<|>INFLAMMATORY BOWEL DISEASE<|>Rosa Mª Mirete López treated the patient who was suffering from inflammatory bowel disease<|>7)\n##\n(\"relationship\"<|>ILEOSTOMY<|>DIABETES MELLITUS<|>The ileostomy was performed on the patient who had diabetes mellitus as a complication of her condition<|>5)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>DIABETES MELLITUS<|>Nutritional support was provided to the patient with diabetes mellitus during her hospitalization<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>DIABETES MELLITUS<|>Enteral nutrition was initiated for the patient who had diabetes mellitus<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>NUTRICIÓN ENTERAL<|>Nutritional support transitioned from parenteral to enteral during the patient's treatment<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Bajo o nulo                           Alto                            Nulo\n\n\n\n       Tipo de fibra                             -                  Soluble, prebiótico                           -\n\n\n\n         Aporte de                          15-20%                           15-25%                           18-21%\n         proteínas\n                                                                                                            Proteínas\n     Fuente proteica                         Leche                             Soja                        hidrolizadas(péptidos)\n                                                                        Mejor control                     Osmolaridad\n            Otros                        Bajo coste                        glucémico                          elevada\n                                                                                                         (>400mOsm/l)\n\n\n\n                                                                                                                                   127\n---\n     Bibliografía\n     1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cys-\n     tic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245(4922):1066-\n     73.\n\n\n\n     2.  Southern KW, Munck A, Pollitt R, Travert G, Zanolla L, Dankert-Roelse J, et al. A survey of new-\n     born    screening for cystic fibrosis in Europe. J Cyst Fibros. 2007;6:57e65.\n\n\n\n     3. Farrell PM. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 2008;7:450e3.\n\n\n\n     4. Ballmann M, Hubert D, Assael BM, et al. Repaglinide versus insulin for newly diagnosed diabetes\n     in patients with cystic fibrosis: a multicentre, open-label, randomised trial. Lancet Diabetes Endocri-\n     nol. 2018;6(2):114-121.\n\n\n\n     5.  Solomon M, Bazic M, Mascarenhas M. Nutritional issues in cystic fibrosis. Clin Chest Med.\n     2016;37(1):97-107.\n\n\n\n     6.  Turck D, Braegger CP, Colombo C, et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for\n     infants, children and adults with cystic fibrosis. Clin Nutr. 2016;35(3):557-77.\n\n\n\n     7. Jensen GL, Cederholm T, Correia MITD, et al. GLIM Criteria for the diagnosis of malnutrition: a con-\n     sensus report from the Global Clinical Nutrition Community. JPEN J Parenter Enteral Nutr. 2018;0:1-9.\n\n\n\n128\n---\n  Caso Clínico\nPaciente con diabetes                                  mellitus y\nenfermedad inflamatoria intestinal\nDra. Rosa Mª Mirete López\nMédico Especialista en Endocrinología y Nutrición.\nHospital Universitario de San Juan, Alicante.\n\n\n\nResumen\n         Paciente de 52 años, con diabetesmellitus no conocida previamente, ingresa de\nforma urgente por tumoración abdominal gigante. Durante laparotomía exploradora se\nobjetiva plastrón inflamatorio que precisa drenaje + hemicolectomía derecha ampliada\n+ anastomosis ileotransversa. En el postoperatorio inmediato presenta como complica-\nción una dehiscencia de anastomosis con alta sospecha de fístula intestinal, desarro-\nllando la paciente una sepsis grave por peritonitis fecaloidea que obliga a realizar una\nileostomía terminal en una segunda laparotomía. Ante la persistencia de alto débito\nfecaloideo por drenajes se decide resecar el resto de íleon y realizar una anastomosis\nyeyunocólica, que posteriormente se traduce en una yeyunostomía de descarga por\nincremento progresivo de débito.\n\n\n\n         Durante el ingreso, se realiza balance hídrico y control de iones diarios para\najuste en la nutrición parenteral (NP)/sueroterapia, presentando controles de glucemia\nen objetivos con insulina intrabolsa. Se inicia además de forma temprana nutrición\nenteral (NE) a través de sonda nasogástrica (SNG) con fórmula polimérica estándar en\nperfusión continua, que permitió la retirada de NP a los 4 meses de su instauración con\ncambio de terapia insulínica a pauta bolobasal subcutánea.\n\n\n\n         El control glucémico durante el ingreso es adecuado, y la paciente es dada de\nalta a los 8 meses, con dieta oral precisando NE nocturna con aporte de fluidoterapia\nendovenosa en domicilio, y sin necesidad de tratamiento insulínico. Durante el se-\nguimiento ambulatorio se objetiva ganancia ponderal progresiva con mejoría de los\nparámetros bioquímicos, así como un excelente control de su diabetes con una aGLP1\nsemanal.\n\n\n\nPalabras clave\n         Síndrome de intestino corto, fracaso intestinal, diabetes, nutrición enteral,\ndesequilibrio hidroelectrolítico, aGLP2.\n\n\n\n                                                                                          129\n---\n     Introducción\n              Mujer de 52 años de edad. Antecedentes personales: No alergias medicamentosas.\n     No hábitos t\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}